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Abstract
Infectious pancreatic necrosis virus (IPNV) causes high incidence of disease in salmonids during the first period after SW
transfer. During this period as well as during periods of stress, cortisol levels increase and indications of a relationship
between IPNV susceptibility and cortisol have been suggested. The intestine is an entry route and a target tissue for IPNV
displaying severe enteritis and sloughing of the mucosa in infected fish. The mechanisms behind effects of the virus on the
intestinal tissue and the impact of cortisol on the effect remain unclear. In the present study, Atlantic salmon post smolts
treated with or without slow release cortisol implants were subjected to a cohabitant IPNV challenge. Analysis of genes and
proteins related to the innate and acquired immune responses against virus was performed 6 days post-challenge using
qPCR and immunohistochemistry. An increased mRNA expression of anti-viral cytokine interferon type I was observed in the
proximal intestine and head kidney as a response to the viral challenge and this effect was suppressed by cortisol. No effect
was seen in the distal intestine. T-cell marker CD3 as well as MHC-I in both intestinal regions and in the head kidney was
down regulated at the mRNA level. Number of CD8a lymphocytes decreased in the proximal intestine in response to
cortisol. On the other hand, mRNA expression of Mx and IL-1b increased in the proximal intestine and head kidney in IPNV
challenged fish in the presence of cortisol suggesting that the immune activation shifts in timing and response pathway
during simulated stress. The present study clearly demonstrates that IPNV infection results in a differentiated epithelial
immune response in the different intestinal regions of the Atlantic salmon. It also reveals that the epithelial immune
response differs from the systemic, but that both are modulated by the stress hormone cortisol.
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Introduction
The parr-smolt transformation and the subsequent sea water
(SW) migration are important developmental life stage transitions
for Atlantic salmon during which changes in the endocrine as well
as the immune system occurs [1–3]. The changes in physiology,
anatomy and behavior in order to prepare the fish for a life in SW
are extensively studied, whereas the concomitant changes occur-
ring in the immune system are less well described [4–7]. Both up-
and down-regulation of different innate immune markers during
smoltification and SW transfer have been reported [8,9]. An up-
regulation of immune functions has been accounted stimulatory
effects of thyroid hormones and growth hormone and down-
regulation are suggested to be caused by increased cortisol levels
during these periods [10–13]. However, studies as well as
experience from aquaculture show that there is a window of
about 3 months, starting directly following sea water transfer, with
increased susceptibility to pathogens [14].
Cortisol is one of the main developmental hormones, promoting
hypo-osmoregulatory ability, with a peak during the parr-smolt
transformation and a further increase after transfer to SW [15].
Cortisol is also one of the major stress hormones resulting in
several secondary and tertiary stress responses [16]. Among the
secondary stress responses, a reduced intestinal integrity has been
proposed as a consistent indicator of both acute and chronic stress
[17–19].
Stress is well known to affect the immune system of fish both
systemically and locally, at the intestinal level [13,20–22]. In the
salmon intestine, a down-regulated mRNA expression of IL-1b,
IFNc and an alteration of IL-10 together with an increased
infiltration of neutrophils have been observed as responses to
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various stressors [22]. Stress has therefore been suggested to alter
the salmonid immune response to pathogens [20].
One of the main problems for salmonid aquaculture is the
window of increased susceptibility to infections, e.g. infectious
pancreatic necrosis virus (IPNV), 1-4 weeks after SW transfer [23].
Much effort has been put into investigating the physiological and
immunological mechanisms that control infection and protection
against the virus [24–27]. IPNV is a double stranded RNA virus
belonging to the Aquabirnaviruses of the Birnaviridae family and
infection can lead to high mortality and turn surviving fish into
lifelong carriers of virus [28]. There are several reference types of
the virus, e.g. VR299, Sp and Ab isolated from disease outbreaks
[29]. In Norway, the Sp serotype is commonly used in viral
challenge experiments [24–26]. IPN disease leads to necrosis of
pancreatic acinar cells, liver and kidney [28]. One of the first
target tissues for IPNV is the intestine, where acute enteritis,
sloughing of mucosa and increased paracellular permeability are
commonly observed [30–32]. These early effects of IPNV infection
in the gastrointestinal tract together with the positive demonstra-
tion of translocated virus across the intestine suggests this tissue to
be a major entry route for the virus [31].
The diverse anti-viral response includes secretion of interferon
type I (IFN type I) and II (IFNc) which activate intracellular
signaling pathways, in turn resulting in diverse cellular responses
[33]. In salmonid cells, recombinant IFN increases mRNA
expression levels of STAT1, of the JAK/STAT pathway, followed
by an increased expression of antiviral protein Mx [34]. One of the
evasive mechanisms of IPNV is to inhibit Mx expression in the
host and thereby dampening the effect of STAT1 phosphorylation
[33,34]. The anti-viral defense further includes activation of T
cells in the specific cellular immune response and involves antigen
presentation via the MHC-I complex to CD8 positive T cells [25].
Stress has recently been reported to have marked effects on anti-
viral processes in Atlantic salmon. Repeated stress in combination
with immersion exposure to IPNV resulted in down-regulation of
IFN type I and an increased replication of IPNV [35]. Also, long-
term hypoxia induced stress changed the timing of the intestinal
epithelial immune response towards synthetic double stranded
RNA, poly I:C [20].
Therefore, the aim of the present study was to investigate the
effects of IPNV infection on the local intestinal anti-viral response
in Atlantic salmon and to assess the effect of high circulating levels
of cortisol, as a mimic of stress, on this response.
The intestinal mucosal anti-viral pathways were up-regulated in
response to a cohabitant challenge with IPNV of the Sp strain and
cortisol was shown to suppress these effects. Early immune
markers as well as immune cell markers, mortality and IPNV
prevalence was monitored and are discussed in relation to IPNV
infection and cortisol treatment.
Materials and Methods
Fish
275 Atlantic salmon, hatched in mid-January, were kept in fresh
water (FW) at approximately 10 uC under continuous light (24L),
from first feeding in late February, to reach parr stage (in late
August) at the Institute of Marine Research (IMR) in Matre (61
uN), Norway. Thereafter, the fish were subjected to a transient
change in photoperiod to 12L:12D for 6 weeks followed by 6
weeks of 24L:0D to produce out-of-season smolts [36]. After this
period the smolts, weighing 10863 g, were transported to IMRs
disease challenge laboratory and randomly divided up into eight
150 L flow through FW tanks (8.5 L min21 maintaining O2 at
9.260.2 mg L21 at a water exchange rate of 3.3 times h21,
temperature: 8.960.2 uC). The fish were allowed to acclimatize to
the new tanks for 3 weeks before initialization of the experiment
and were fed a commercial diet (Biomar 50 in FW and Skretting
3 mm) ad libitum, throughout the acclimation and the experi-
mental periods.
The experiment was initialized by a gradual exposure to SW by
changing the inlet from FW to SW (8.5 L min21 maintaining O2
at 9.260.2 mg L21 and a water exchange rate of 3.3 times h21)
over a six hour period (unfiltered 9.360.1 uC SW from 120 m
depth, salinity of 34.5%). Thereafter, the fish were left undisturbed
for 10 days before implantation of cortisol (in mid-November). All
fish were treated according to the Norwegian national legislation
for laboratory animals throughout the experiment. The experi-
ment was approved by Forsøksdyrutvalgets tilsyns- og søknadssys-
tem (FOTS), Mattilsynet, Forsøksdyrutvalget, Brumunddal, Nor-
way as stated in ethical permit 08/48706. The experiment was
carried out using a minimum critical mass of animals to avoid
hierarchy formation or over-crowding. The animals and water
conditions were under daily surveillance throughout the experi-
ment. Injected fish were allowed to recover for 24 hours before
their status was inspected. Any animal showing signs of abnormal
behavior, reduced swimming capacity or with visible injuries were
netted, anesthetized and euthanized. During the recovery period
of 10 days after SW exposure and before cortisol implantation,
there was a mortality of six fish randomly distributed over the 8
tanks. After cortisol or vehicle implantation one fish in one of the
cortisol implanted groups diseased.
Cortisol implants
Ten days after SW introduction, all fish from 6 of the 8 tanks
were randomly netted, anesthetized in metomidate (,6 mg L21)
and intraperitoneally (i.p.) implanted with a slow release implant
with or without cortisol (+F/-F) and returned to their respective
tank (n = 36, density 22 kg m23). The remaining two tanks were
maintained as non-treated controls throughout the experiment.
Fish in the +F group received cortisol (Sigma-Aldrich Sweden
AB, Stockholm, Sweden), at a dose of 50 mg g21 body weight (BW)
dissolved in vegetable oil:vegetable shortening 1:1, at a volume of
5 mL g21 BW and the -F group received the implant without
cortisol at the same volume. The cortisol implants have been
shown to result in increased circulating levels of cortisol in the fish
up to one month [37].
In the present study the cortisol implants resulted in a
significantly increased plasma level of cortisol in the +F group
compared to –F and non-challenged controls as reported
previously [31]. In the +F group the average level of cortisol was
319.2 6 46.9 ng mL-1, in the –F group 9.762.9 ng mL-1 and in
the non-implanted control 6.761.9 ng mL-1, respectively.
Cohabitant IPNV challenge
One week after implantation, the cohabitant challenge was
started (day 0). Six implanted fish (+F/-F) from each tank were
randomly netted, anesthetized in metomidate (,6 mg L21) and
i.p. injected with a viral dose of 1 6107 TCID50 (200 mL) of IPN
virus, of the Sp strain, and re-introduced to their respective tanks
[29,31]. The injected fish functioned to challenge the remaining
fish in the tank as cohabitants and were adipose-fin clipped to
distinguish them from the non-injected fish. This experimental
design resulted in 3 treatment groups, one infected with IPNV and
implanted with cortisol (+IPNV+F), one infected with IPNV and
implanted with vehicle (+IPNV-F) and one non-challenged and
non-implanted control (-IPNV). Mortality of non-injected fish was
monitored daily in the +IPNV+F and +IPNV-F groups from start
of the IPNV challenge up to 41 days post-challenge.
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Sampling
After 6 days of cohabitant exposure (day 12), head kidney and
intestinal samples were taken for a total of 9 fish from each group
(3 fish per tank of the implanted fish and alternating 4 or 5 fish per
non-implanted control tank). Fish were euthanized with a lethal
dose of metomidate (,12.5 mg L21) and followed by a sharp blow
to the head. Head kidney samples were placed in liquid nitrogen
for later mRNA extraction. The intestine was divided into a
proximal and a distal part and a small circular portion of each part
was cut out and placed in Hollande’s fixative for 24 h at 4uC,
washed and transferred to 70% EtOH and stored for immuno-
histochemistry analysis. The remaining intestinal parts were cut
longitudinally and the mucosa was scraped of and placed in liquid
nitrogen for quantitative PCR (qPCR) analysis. A final sampling of
proximal intestine and head kidney from +IPNV+F and +IPNV-F
fish was performed at day 28 to examine degree of infection by
qPCR analysis.
qPCR
The mRNA expression of immune markers was assessed using
qPCR. Tissue samples were homogenized using a Precellys
homogenizer (Bertin, France). Approximately 30 mg of each
sample were placed in tubes with TRIzol (Invitrogen/Life
Technologies Ltd, Paisley, UK) and ceramic beads, Lysing Matrix
D (Q-Biogene/MP Biomedicals, Illkirch, France). The RNA was
extracted using an iPrep Purification Instrument (Invitrogen/Life
Technologies Ltd, Paisley, UK). The RNA quality of randomly
selected samples was analyzed in the Bioanalyzer system and the
RNA was quantified using a Nanodrop (Thermo, Scientific,
Wilmington, USA) and diluted to obtain 2000 ng total RNA per
sample. cDNA was synthesized using the Invitrogen SuperScript
III First-Strand Synthesis System (Life technologies Ltd, Paisley,
UK) with random primers in 20 ml final reaction volume.
The qPCR assays used are listed in Table 1. Primers and
hydrolysis probes (FAM-MGBNFQ; Applied Biosystems/Life
Technologies Ltd, Paisley, UK) were verified using NCBIs BLAST
tool (NCBI, Bethesda, USA) and efficiencies tested in the Bio-Rad
iQ5 Real-Time PCR Detection System (Bio-Rad, Sundbyberg,
Sweden). Hydrolysis probes were designed to bind over a splicing
site to avoid amplification of potential genomic DNA contamina-
tion. The concentrations used for all primers were 900 nM and for
all probes, 250 nM. All samples were analyzed in duplicate with
ELF1a as reference gene based on previous work on reference
gene stability [38]. In the distal intestine the reference gene
showed lower expression in the +IPNV+F group compared to the
+IPNV-F group (average Ct 6 1) but not to -IPNV. Therefore, a
second reference gene, 18S rRNA, was tested. This reference gene
has previously been shown to be stable in the intestine during viral
challenge experiments [39] and proposed to be a good reference
gene in tissues with high cell turnover [40,41]. However, also the
18S gene showed a lower expression level in the distal intestine of
the +IPNV+F group. For normalization of the mRNA expression
of target genes in the distal intestine a geometric average of the two
reference genes was used [42]. TaqMan qPCR was performed
using commercial qPCR Master Mix No ROX Kit (Eurogentec,
Liège, Belgium) in 20 mL reactions. The relative expression was
calculated using the cycle threshold (Ct) number and the slope of










Primers for RNA expression of VP1, the RNA polymerase of
IPNV, were previously published in Gadan et al 2012 [43] and
used in 1000 nM concentrations for SYBRGreen detection of
amplification after verification on the iQ5 platform, using the iQ
SYBRGreen Supermix commercial kit in 20 mL reactions (Bio-
Rad, Sundbyberg, Sweden). ELF1a was used as reference gene
and melting curve analysis was used to verify specific products.
Samples showing Ct,35 was considered positive for IPNV and
are presented as filled circles in the mRNA expression figures.
Immunohistochemistry
The presence of CD8a, MHC-I and Mx was assessed by
immunohistochemistry (IHC). For CD8a, a mouse monoclonal
CD8a antibody, validated by Hetland et al [44], was used. For
MHC-I a mouse monoclonal antibody was generated against the
recombinantly expressed MHC-I heavy chain a 3 domain from
Atlantic salmon. The reactivity of this antibody was validated by
western blot on salmon red blood cells and by immunoprecipi-
tation on biosynthetic labeled salmon spleen cells. For Mx protein
expression, a polyclonal rabbit Ab directed against Atlantic salmon
Mx was used [45]. At the time of analysis, tissue sections were
dehydrated through an alcohol gradient, Histolab-clear (Histolab
products, Västra Frölunda, Sweden) and imbedded in paraffin
wax. Sections (6 mm) were sliced from proximal and distal
intestines and mounted on 3’-aminopropyltriethoxysilane (APES;
Sigma-Aldrich Sweden AB, Stockholm, Sweden) coated slides,
dried at 37 uC for 24 h. Then the slides were dewaxed in Histolab-
clear followed by rehydration in a series of alcohol baths followed
by 1610 min in ddH2O. The slides were then soaked in Tris
buffered saline (6.06 g l-1 Tris HCl, 1.39 g l-1 Tris base, 9 g l-1
NaCl; pH 7.6) supplemented with 0.05% Tween-20 (TBST)
265 min. For two of the antibodies, mouse monoclonal CD8a
and MHC-I, sections were subjected to epitope retrieval in Tris/
EDTA (10/1 mM; pH9) containing 0.05% Tween-20 for 30 min
at 100uC. Endogenous peroxidase activity was blocked by
immersion in 0.3% H2O2 (in TBST:Methanol 7:3) for 30 min at
room temperature (RT) and then washed in TBST, 363 min. The
slides were incubated with blocking solution (3% BSA, 5% normal
goat serum and 5% normal donkey serum) in TBST for 1 h at RT.
Excess blocking solution was removed and sections were incubated
with 100 ml primary antibody diluted in blocking solution (CD8a;
1:200, MHC-I alpha 3; 1:600 and Mx 1:4000) overnight in a
humid box at 4 uC. Blocking solution without primary antibody
served as controls. Thereafter, all incubations were performed at
RT. The slides were washed in TBST 363 min and incubated
with a biotinylated secondary Ab for 1 h. Thereafter the slides
were washed in phosphate buffered saline (PBS; pH 7.2) with
0.05% Tween-20 (PBST) 363 min and incubated with 100 ml
Vectastain Elite ABC reagent (according to Vector kit instructions)
for 30 min followed by NovaRED peroxidase substrate solution
(according to Vector kit instructions) for 7 min, then washed again
for 10 min in running tap water, dehydrated in alcohol gradient
followed by Histolab-clear and mounted with Pertex (Histolab
Products AB, Västra Frölunda, Sweden). For assessment of the
number of CD8a positive cells, pictures were taken using a Nikon
Eclipse E1000 microscope equipped with a Nikon DXM 1200
digital camera. The pictures were imported into Biopix iQ
software (Bio Pix AB, Gothenburg, Sweden) where the number of
cells in the intestinal epithelium divided by the length of epithelia
observed were determined. The immune staining of MHC-I and
Mx was scored from 0-5 where 5 was the highest color intensity
observed. For Mx, the scoring was divided between Mx expressed
in the enterocytes and expression in other cell types such as in
goblet cells, termed other.
IPNV and Cortisol on Salmon Mucosal Immunity
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Statistics
The data was analyzed using a 1-factorial analysis of variance
(ANOVA) followed by Tukeys post hoc test. Homogeneity was
tested using Levenes test and data not passing the test were
transformed using log10 transformation. Heterogeneous data and
semi-quantitative scores for MHC-I and Mx protein expression
were subjected to Kruskal-Wallis non-parametric test followed by
Bonferroni corrected Mann-Whitney U test to determine differ-
ences between groups. Statistical tests were performed using SPSS
18.0 (SPSS Inc., Chicago, Illinois). All data were expressed as
means6SEM and p,0.05 was regarded as significant. The
difference in survival rate was assessed using a Kaplan Meier
approach [46].
Results
The cumulative mortality curves were sigmoidal in shape for
both groups and no statistical difference was found between the
two treatments. However, mortality started in the +IPNV+F group
at day 4 post-challenge (i.e. introduction of cohabitant fish; Fig. 1A)
whereas it did not start until day 12 in the +IPNV-F group and the
slope appeared steeper in this group. Viral RNA coding for VP1
was found in 26% of the fish analyzed at day 6 (33% in the +
IPNV-F and 18% in the +IPNV+F group) and in72% at day 28
post-challenge (78% in the +IPNV-F and 67% in the +IPNV+F
group; Fig. 1B). Further, there seems to be a higher expression of
the viral protein in the head kidney compared to the proximal
intestine after 28 days of cohabitant challenge as suggested by the
higher relative expression values in the head kidney (Fig. S1).
Table 1. Primers and probes used for qPCR.
Gene Sequence Accession number Ref
ELF a1 Forward GCCCCTCCAGGACGTTTA AF321836 [48]
Reverse CGGCCCACAGGTACAGTT
Probe CCAATACCACCGATTTTG
IFN type I Forward ACTGAAACGCTACTTCAAGAAGTTGA AY216595, AY216594 [48]
Reverse GCAGATGACGTTTTGTCTCTTTCCT
Probe CTGTGCACTGTAGTTCATTT
Mx1 and 2 Forward CCACCCTACAGGAGATGATGCT U66475, U66476 [20]
Reverse ATCTGATCAGCCAAACGTTGACT
Probe CTCAAGTCCTATTACAGGATATC
CD3cd Forward TGATCACCGGCAAGAAAACATCT EF421418, EF421419 [70]
Reverse TTTGCACTCGCCTCATTGC
Probe ATGAGCCCCATTTTGCT
CD8a Forward AGAACGAAACGATGCCCACAT AY693391, Y693393, AY701521 [71]
Reverse CTGTTGTTGGCTATAGGATGTTGTTG
Probe TTCTCGGCTGTCTTTTG
MHC-I Forward GCGACAGGTTTCTACCCCAGT AF504013-25 [72]
Reverse TGTCAGGTGGGAGCTTTTCTG
Probe TGGTGTCCTGGCAGAAAGACGG
IL-1b Forward GCTCAACTTCTTGCTGGAGAGT AY617117 [48]
Reverse GGGCGCCGACTCCAA
Probe CTCCAACACTATATGTTCTTCC
IFNc Forward GCTGTTCAACGGAAAACCTGTTT AJ841811, AY795563 [48]
Reverse GTCCAGAACCACACTCATCCA
Probe TCACTGTCCTCAAACGTG
IL-10 Forward CCGTTTGACATCAAC GAGTTCATCT AB118099 [73]
Reverse CAGCTCTCCCATTGCCTTATACAG
Probe CCTTATCCTGCATCTTCT
18S Forward CCCCGTAATTGGAATGAGTACACTTT AJ427629 [39]
Reverse ACGCTATTGGAGCTGGAATTACC
Probe CTTTAACGAGGATCCATTGG
VP1 Forward CTGGTCCAGAAACCCTAAGAC AY379740 [43]
Reverse GTGTGTATCTCTCCCCTTTTGG
The table shows the primers and hydrolysis probes (FAM-MGB NFQ probes; Applied Biosystems/Life Technologies Ltd, Paisley, UK) used for qPCR analyses of mRNA
expression. The primers used for SYBRGreen detection of the IPNV polymerase VP1 is shown in the last row.
doi:10.1371/journal.pone.0094288.t001
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Six days of IPNV challenge resulted in a significantly higher
IFN type I mRNA expression in the proximal intestine in +IPNV-
F treated fish compared to the -IPNV group. Further, the
proximal intestine and head kidney of +IPNV-F treated fish
showed higher mRNA expression of IFN type I compared to the +
IPNV+F group (Fig. 2). The cortisol implant in the +IPNV+F
group abolished the effect of the immune challenge on mRNA
expression of IFN type I, as this did not raise above background
level (-IPNV) after implantation with cortisol. In the proximal
intestine, the mRNA expression of Mx was higher in the +IPNV+
F group compared to the +IPNV-F and the –IPNV, while in the
head kidney the Mx expression was higher in the +IPNV+F group
compared to the –IPNV group (Fig. 2). This was supported by a
higher staining intensity for Mx in the enterocytes of the proximal
intestine in the +IPNV+F group as compared to the -IPNV
(Kruskal-Wallis p,0.05; Table 2). No significant differences were
observed in the distal intestine (Fig. 2). In general, Mx staining was
observed in a supra nuclear position of enterocytes as well as in the
most apical part of the enterocytes in the microvilli region (Fig. 3).
Positive staining could also be observed in other cell types such as
goblet cells and cells in the lamina propria (Fig. 3).
CD3 mRNA expression was significantly higher in the proximal
intestine after 6 days of IPNV challenge (+IPNV-F group)
compared to the -IPNV group and the +IPNV+F group (Fig. 4).
The +IPNV+F group had significantly lower CD3 mRNA
expression in the distal intestine than the -IPNV group and the
+IPNV-F group (Fig. 4). No significant effect was seen in the head
kidney (Fig. 4). Neither 6 days of IPNV challenge nor cortisol
treatment resulted in any significant effects in CD8a mRNA
expression (Fig. 4). However, IHC revealed a significantly lower
number of CD8a expressing cells in the proximal intestine of the +
IPNV+F group compared to the -IPNV (Table 3). In both
intestinal segments the MHC-I mRNA expression was significantly
lower in the +IPNV+F group compared to the -IPNV group
(Fig. 4). In the distal intestine, the mRNA expression in the +
IPNV+F group was further significantly different also when
compared to the +IPNV-F group (Fig. 4). The MHC-I immune
reactivity was abundant on the enterocytes, located to the
basolateral and basal sides and in close connection to the CD8a
immune reactive cells which were mainly present near the basal
ends of the enterocytes (Fig. 5 A-D). No significant differences in
MHC-I immune staining between the treatment groups could be
found using IHC analyzes (Table 4).
IL-1b mRNA expression was elevated in the proximal intestine
in cortisol implanted infected fish compared to the –IPNV group,
whereas no effect was seen by IPNV alone (Fig. 6). There was
further a significantly higher mRNA expression in the head kidney
+IPNV-F group and the +IPNV+F group compared to the -IPNV
group (Fig. 6). No significant effect was seen in the distal intestine
(Fig. 6). The treatments did not affect IFNc or IL-10 mRNA
expression 6 days post-challenge (Fig. 6).
Discussion
In the current study, cortisol implants resulted in elevated
plasma cortisol levels within the range observed during a stress
response [31]. Further, fish were successfully infected with IPNV
through natural infection routes created by a cohabitant challenge.
IPNV infection was verified both after 6 and 28 days of the
challenge, as observed by the presence of viral VP1 transcripts in
26% and 72% of the examined fish, respectively. Further, after 28
days the RNA expression in the head kidney was higher than in
the intestine in both infected groups suggesting a viral manifes-
tation in the tissue. The head kidney is routinely used in IPNV
diagnostics and the presence of virus in the kidney is normally
detected within a week in infected fish [47,48]. Since viral mRNA
was found also in the intestine (Figs. 2, 4 and 6), the results verifies
this as a likely route of infection and the head kidney as a viral
target.
The higher mRNA expression of IFN type I, found in the +
IPNV-F group compared to both –IPNV and +IPNV+F fish, in
the proximal intestine and the head kidney is indicative of the early
innate anti-viral response [43]. The simulated chronic stress in
terms of elevated plasma cortisol levels, suppresses the response
both systemically and locally in the intestine. Accordingly, Atlantic
salmon fry infected with IPNV and subjected to repeated stress for
7 days showed a suppressed expression of IFN type I mRNA [35].
Reduced IFN type I mRNA expression of in vitro isolated head
Figure 1. Mortality and IPNV prevalence following IPNV cohabitant challenge and cortisol treatment. Cumulative mortality during the
experimental period in the +IPNV-F group and the +IPNV+F group (A) and the IPNV prevalence as analyzed by VP1 RNA expression 6 and 28 days
post-challenge (B). 6 days post-challenge VP1 was detected in 33% and 18% of the examined fish from the +IPNV-F and +IPNV+F groups respectively
(total average 26%). 28 days post-challenge 78% and 67% of the fish was tested positive from the +IPNV-F and +IPNV+F groups respectively (total
average 72%).
doi:10.1371/journal.pone.0094288.g001
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kidney macrophages was also observed when Atlantic salmon post
smolts were subjected to chronic husbandry stress and immune
challenge by poly I:C treatment [20].
One of the mechanisms of the IFN type I pathway to inhibit
viral replication is through up-regulation of Mx [24]. In the +
IPNV+F group there is an increased mRNA as well as protein
expression of Mx in the proximal intestine and an increased Mx
mRNA expression in the head kidney without up-regulation of
IFN type I. The observed divergences in IFN type I and Mx
mRNA expression could be explained by a difference in timing
between treatment groups as well as individuals. For example, a
sampling capturing an early point in IFN type I pathway
activation may show an increased IFN type I mRNA expression
without any increased expression in Mx mRNA. Along this line,
the Mx mRNA expression in the +IPNV+F group may be
activated by stimulatory action by IFN type I that have returned to
basal levels at day 6. However, the discrepancies can also reflect an
anti-viral response induced by other cytokines than IFN type I. In
this respect, IL-1b and IFNc has been suggested as possible Mx
inducers [49,50]. For example, the functional P1 domain of IL-1b
was shown to induce Mx expression in rainbow trout after intra-
peritoneal injection [50]. In the present study, IL-1b but not IFNc
mRNA is up-regulated in both proximal intestine and head kidney
in support of such regulatory effect by IL-1b. Furthermore, an
overall immunosuppressive effect of cortisol could result in
increased virus replication, which in turn would increase the Mx
expression [20,35]. In the infected, vehicle implanted fish, on the
other hand, there is no increased Mx mRNA expression despite an
increased mRNA expression of IFN type I. This could suggest an
IPNV dependent inhibition of the Mx mRNA expression at the
time of sampling and hence a suppression of the anti-viral response
at the level of Mx. There have been reports of a balance between
the IPNV infection process and the IFN type I/Mx activation
process [51]. Cells pre-treated with recombinant IFN type I
suppressed IPNV proliferation while the anti-viral response was
inhibited at the Mx promoter region level when the cells were
already infected [51].
The enterocyte distribution of Mx, being supra nuclear as well
as close to or in the apical membrane is intriguing. In a majority of
vertebrate species, two or more different genes of Mx have been
characterized and different protein isoforms with different
functions have been suggested [52]. Presence of Mx in the
cytoplasm close to the nucleus is believed to have a protective role
against viral replication [24], whereas a more apical localisation of
Mx and presence in mucus secreting cells may indicate the
possibility of a secretory form of Mx [53,54]. Ovine Mx1 is
secreted with exosomes from uterus epithelial cells [53] and
suggested to regulate unconventional vesicular secretory processes
[54]. The localization of Mx in the most apical region of the
enterocytes as well as in the goblet cells, as shown in the present
study, resembles previous observations also in the gills of Atlantic
salmon [45]. Thus, the possibility of several Mx isoforms as well as
secretory forms, equivalent to the mammalian Mx1, in salmonids
merits further investigation.
Figure 2. mRNA expression of IFN type I and Mx 6 days post-challenge. mRNA expression of IFN type I in the proximal intestine (n = 7, 7, 9),
distal intestine (n = 8, 8, 7) and in the head kidney (n = 7, 7, 8) and mRNA expression of Mx in the proximal intestine (n = 8), distal intestine (n = 8) and
in the head kidney (n = 8, 7, 8). The VP1 positive fish 6 days post-challenge is presented as filled circles and the red line corresponds to the average
value of the treatment group. Different letters denote statistically significant differences among the groups according to Tukeys post hoc test. For Mx,
Kruskal-Wallis non-parametric test was used followed by Bonferroni corrected Mann-Whitney U test to determine differences between groups.
Outliers with values outside average 6 2 x SD were omitted. Statistical significance was accepted at p,0.05.
doi:10.1371/journal.pone.0094288.g002
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CD3 is expressed on all T cells as a part of the T cell receptor
complex and is involved in signal transduction upon receptor
activation [55]. The increased CD3 mRNA expression in the
proximal intestine of the +IPNV-F group compared to the non-
challenged group, indicate that T-cells are important in this
intestinal region during an IPNV infection. The increased CD3
mRNA expression is not accompanied by increases in CD8a or
MHC-I mRNA expression in this intestinal region and treatment
group. This may indicate an early T cell proliferation and a
differentiation of T cells, e.g. Tregs or Th cells, towards CD4
expression rather than CD8 [25]. The absence of effect on the
CD8/MHC-I system by the IPNV challenge, could also be an
effect of sampling time, i.e. that this part of the intestinal mucosal
immune system still show basal expression levels at day 6 post-
challenge. In both intestinal regions the mRNA expression of CD3
is significantly lowered by the cortisol treatment in the IPNV
challenged fish (+IPNV+F). This suggests an immunosuppressive
effect of the stress hormone on T-cells [56]. In concordance with
the results on CD3 mRNA expression, the MHC-I mRNA
expression as well as the number of CD8a lymphocytes are
decreased in response to cortisol. These results give further support
to an immunosuppressive effect of cortisol on the response
mediated by cytotoxic T-cells. The intestinal epithelial immune
system is constantly exposed to a large variety of antigens, which
probably results in high constitutive expression levels as indicated
by the ability of cortisol to suppress these markers. In mammals,
Figure 3. Tissue localization of Mx immune staining in the proximal and distal intestine. Tissue sections, after 6 days of cohabitant
challenge, from proximal intestine (A and B) and distal intestine (C and D). Scale bar 50 mm. Epithelial cells (e) lining the villi (v) show supra nuclear
presence of Mx (arrow). Mx is also present in the most apical part of the enterocytes in the micro villi region (arrowhead). Staining could also be found
in goblet cells (g) (*). The lamina propria (lp) and intestinal lumen (l) are featured for clarity.
doi:10.1371/journal.pone.0094288.g003
Table 2. Mx immune staining 6 days post-challenge.
Mean score of Mx in the intestine
-IPNV (n = 3) +IPNV-F (n = 6) +IPNV+F (n = 5)
Mean SEM Mean SEM Mean SEM
Proximal intestine
Enterocyte (p,0.05) 3.6a 0.22 3.9ab 0.35 4.7b 0.12
Other 2.0 0.26 3.0 0.27 2.2 0.29
Distal intestine
Enterocyte 2.9 0.22 2.7 0.20 2.8 0.27
Other 2.8 0.17 3.4 0.23 2.9 0.42
The Mx immune reactivity in the proximal and distal intestine was scored 0-5 with 5 being the most abundant reactivity (n = 3-6). The expression in enterocytes was
separated from the expression in other cell types such as goblet cells and leucocytes, termed other. Statistical difference was accepted at p,0.05 as determined by
Kruskal-Wallis non-parametric test followed by Bonferroni corrected Mann-Whitney U test to determine differences between groups.
doi:10.1371/journal.pone.0094288.t002
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MHC-I and II are present on intestinal epithelial cells (IECs) and
increases in abundance as a response to infection as well as stress
[57]. IECs act as antigen sampling and antigen presenting cells
and activate CD8a positive cells [58]. The overall higher
expression of CD8a protein in the distal intestine compared to
the proximal intestine could therefore be an evidence for a higher
level of antigen sampling and presentation in this area.
A cohabitant challenge results in viral exposure through the
primary barriers. In fish, these are the skin, gills and the
gastrointestinal tract, with the intestine positively demonstrated
as an entrance route for IPNV [32]. Through the ingested water,
the proximal intestine becomes exposed to the viral particles first
and there is probably an initially higher load of virus in this
segment compared to the distal intestine. This is further indicated
by assessment of the intestinal permeability after viral infection,
which was shown to be more affected in the proximal compared to
the distal intestine [32]. Furthermore, binding of virus to mucus
secreted along the intestine may result in the creation of a mucus
tube with trapped virus particles in the intestinal lumen, leading to
a lesser degree of viral exposure further down in the intestine
[59,60]. Therefore, the proximal intestine is a likely target tissue
for the initiation of IPNV infection. In this study, the effect on
immune response markers is similarly more evident in the
proximal intestine compared to the distal intestine after 6 days
of cohabitant challenge suggesting an earlier and/or greater
exposure to the virus in the proximal intestine. Accordingly,
previous studies on salmonids demonstrates more pronounced
effects in the proximal compared to the distal intestine in terms of
visible signs of infection as well as immune response against the
virus [30,31,61].
A distinguished feature of the response towards many virus,
including IPNV, is an increase in IFN type I expression and the
presented results show a significant increase in both the head
kidney and proximal intestine in the +IPNV-F group 6 days post-
Figure 4. mRNA expression of CD3, CD8a and MHC-I 6 days post-challenge. mRNA expression of CD3 in the proximal intestine (n = 9, 8, 9),
distal intestine (n = 9, 8, 8) and in the head kidney (n = 8, 7, 8), mRNA expression of CD8a in the proximal intestine (n = 9, 8, 9), distal intestine (n = 8)
and in the head kidney (n = 8, 7, 8) and mRNA expression of MHC-I in the proximal intestine (n = 9, 8, 9), distal intestine (n = 9, 8, 8) and in the head
kidney (n = 8, 7, 8). The VP1 positive fish 6 days post-challenge is presented as filled circles and the red line corresponds to the average value of the
treatment group. Different letters denote statistically significant differences among the groups according to Tukeys post hoc test. Statistical
significance was accepted at p,0.05.
doi:10.1371/journal.pone.0094288.g004
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challenge. Concomitantly, the mortality curves indicate an initially
lower mortality in the +IPNV-F group compared to the +IPNV+F
group despite more VP1 positive individuals detected in this
group. Similarly, McBeath et al [48] showed lower level of viral
transcripts in non-injected fish compared to injected cohabitants
and this was concomitant with a higher mortality rate. Hence,
there is no clear correlation between high levels of viral transcripts
and mortality, which may be a result of an increased anti-viral
defense through increased expression of IFN type I.
Variations in expression of IFN type I as well as in other
markers was found. IPNV infections can result in high mortalities
in susceptible individuals but also in persistent virus carrying cells
in surviving fish. It is therefore likely that the response differs
depending on the predisposition of an individual to the latent or
the lethal form of IPN disease [62]. In the +IPNV-F group, fish
expressing RNA for the polymerase VP1 generally also expressed
higher or lower than average mRNA levels of anti-viral markers
IFN type I, IFNc and Mx (Fig. 2 and 6). The overall picture
suggests a high mRNA expression of anti-viral markers in the VP1
positive fish in response to IPNV infection and a suppression of
this response in the presence of cortisol. Further, IL-1b mRNA
expression was increased in the head kidney of both infected
groups with VP1 positive fish showing expression above the group
average. This is in line with previous findings and could potentiate
the hypothesis that the large amounts of macrophages present in
the head kidney give rise to increased levels of the cytokine in
infected fish [63]. A time dependent increase in IL-10 mRNA
expression has been observed in the head kidney of IPNV infected
persistent fish and this immune modulator may account for a
decreased mortality rate in infected fish through a dampening of
the inflammatory processes [63]. In the present study, some VP1
positive fish in the +IPNV-F group showed a high mRNA
expression of IL-10 while others were at intermediate expression
level.
In a cohabitant challenge with IPNV, mortality is expected in
the injected cohabitants after 1-2 weeks while disease and increase
Figure 5. Tissue localization of MHC-I and CD8a immune staining in the proximal and distal intestine. Tissue sections, after 6 days of
cohabitant challenge, showing presence of MHC-I in the proximal intestine (A and B) and distal intestine (C). Scale bar 50 mm. Epithelial cells (e) lining
the villi (v) show staining of MHC-I in the basal (*) and lateral region (arrowhead) of the epithelial cells. MHC-I is also observed as a band in the supra
nuclear region of the enterocytes (arrow). Interspersed goblet cells (g) and lamina propria (lp) and luminal space (l) featured for clarity. Presence of
CD8a in the proximal intestine is shown lining the space between the epithelial cell layer and the lamina propria (arrow; D).
doi:10.1371/journal.pone.0094288.g005
Table 3. CD8a immune staining 6 days post-challenge.
Number of CD8a+ lymphocytes * mm-1 epithelia
-IPNV (n = 3) +IPNV-F (n = 6) +IPNV+F (n = 6)
Mean SEM Mean SEM Mean SEM
Proximal intestine (p,0.05) 32.0a 7.0 21.1ab 2.9 15.1b 1.3
Distal intestine 36.2 6.3 35.8 4.6 32.9 2.6
The number of CD8a expressing lymphocytes presented as number of cells in the proximal and distal intestinal epithelium divided by the length of epithelia observed
(n = 3-6). Different letters indicate statistical differences after Tukeys post-hoc test. Statistical difference was accepted at p,0.05.
doi:10.1371/journal.pone.0094288.t003
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in mortality in the non-injected fish is expected after 2-4 weeks
[48,64,65]. In the vehicle implanted group, mortality of non-
injected fish started at day 12 post-challenge, a time of onset well
in line with previous studies, whereas there was an earlier onset of
mortality (day 4) in the cortisol implanted group. A similar early
mortality onset (day 3, post-IPNV challenge) has been seen shown
Table 4. MHC-I immune staining 6 days post-challenge.
Mean score of MHC-I in the intestine
-IPNV (n = 3) +IPNV-F (n = 6) +IPNV+F (n = 5)
Mean SEM Mean SEM Mean SEM
Proximal intestine 4.6 0.19 4.1 0.18 3.8 0.35
Distal intestine 3.9 0.08 3.7 0.14 4.1 0.26
The MHC-I immune staining in the proximal and distal intestine was scored 0-5 with 5 being the most abundant staining (n = 3-6). Statistical difference was accepted at
p,0.05.
doi:10.1371/journal.pone.0094288.t004
Figure 6. mRNA expression of IL-1b, IFNc and IL-10 6 days post-challenge. mRNA expression of IL-1b in the proximal intestine (n = 4, 7, 8),
distal intestine (n = 7, 9, 9) and in the head kidney (n = 8, 7, 8), mRNA expression of IFNc in the proximal intestine (n = 8, 9, 8), distal intestine (n = 8, 9,
9) and in the head kidney (n = 7, 7, 8) and mRNA expression of IL-10 in the proximal intestine (n = 8, 9, 8), distal intestine (n = 7, 9, 9) and in the head
kidney (n = 8, 7, 8). The VP1 positive fish 6 days post-challenge is presented as filled circles and the red line corresponds to the average value of the
treatment group. Different letters denote statistically significant differences among the groups according to Tukeys post hoc test. Statistical
significance was accepted at p,0.05.
doi:10.1371/journal.pone.0094288.g006
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in cohabitantly challenged Atlantic salmon smolts exposed to
environmental stress [66]. Furthermore, the time for onset of
mortality can be stock density dependent and fish densities
corresponding to the densities used in the current study (over
16 kg m-3) has previously resulted in mortalities as early as day 3
post-IPNV challenge [67]. The early onset in mortality in the
cortisol implanted group could therefore be a result of the density
of fish in the tanks together with the cortisol treatment, mimicking
a stress response. The cumulative mortality at the end of the
present experiment reached approximately 20% in both groups,
which is within the range of previously reported mortalities for
cohabitant challenges.
The mortality data thus suggest that cortisol enhance the onset
of mortality in IPNV cohabitants, with a steady increase in
mortality in the +IPNV+F group up to day 41 at which point the
mortality in the +IPNV-F group have risen to approximately the
same level. This is well in line with the demonstrated suppressive
effect of cortisol on several of the immune parameters assessed,
especially in the intestinal epithelial immune system. The results
further indicates that the infection and hence immune response is
activated but in an early state day 6 post-challenge.
Conclusions
IPN disease outbreak depends on an intricate balance between
the innate and acquired immune response of the host, cell
signaling and internal pathways and virus induced alteration of
immune function [68,69]. The current study show an up-
regulation of the anti-viral cytokine IFN type I in the proximal
intestine with a subsequent suppression of this cytokine by cortisol.
There is further a down-regulation of the T cell marker CD3 and
MHC-I in response to cortisol treatment. In terms of general
response towards IPNV, there is a clear induction of immune
markers in the proximal intestine whereas the distal intestine is
affected by cortisol but show weaker response towards the
pathogen. The head kidney mRNA expression data corresponds
to the proximal intestine in terms of the anti-viral response and an
increase is seen in the pro-inflammatory cytokine IL-1b in
response to IPNV infection. There is however a lesser effect on
the cellular immune response in the head kidney.
Therefore, the present study clearly demonstrate differentiated
epithelial immune responses in different regions of the intestine as
well as a local immune response different from the systemic, in
response to IPNV infection as well as to cortisol treatment in
Atlantic salmon.
Supporting Information
Figure S1 RNA expression of VP1 in the head kidney
and intestine 28 days post-challenge. RNA expression of
VP1 in the head kidney (n = 4, 5) and in the proximal intestine
(n = 6, 5). No significant difference was found between treatments
28 days post challenge. * denote statistically significant difference
between tissues according to Tukeys post hoc test. Statistical
significance was accepted at p,0.05.
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26. Saint-Jean SR, Pérez-Prieto SI (2006) Interferon mediated antiviral activity
against salmonid fish viruses in BF-2 and other cell lines. Vet Immunol
Immunopathol 110: 1–10.
27. Wolf K, Quimby MC (1971) Salmonid viruses: infectious pancreatic necrosis
virus. morphology, pathology and serology of first European isolations. Arch
Gesamte Virusforsch 34: 144–156.
28. Evensen Ø, Santi N (2008) Infectious pancreatic necrosis virus. In: Mahy BWJ,
van Regenmortel MHV, editors. Encyclopedia of Virology, 3rd edition. Oxford,
Elsevier. pp 83–89.
29. Hill BJ, Way K (1995) Serological classification of infectious pancreatic necrosis
(IPN) virus and other aquatic birnaviruses. Annu Rev Fish Dis 5:55–77.
30. McKnight IJ, Roberts RJ (1976) The pathology of infectious pancreatic necrosis.
I. The sequential histopathology of the naturally ocurring condition. Br Vet J
132: 76–85.
31. Sundh H, Calabrese S, Jutfelt F, Niklasson L, Olsen RE, et al. (2011)
Translocation of infectious pancreatic necrosis virus across the intestinal
epithelium of Atlantic salmon (Salmo salar L.). Aquaculture 321: 85–92.
32. Sundh H, Olsen RE, Fridell F, Gadan K, Evensen Ø, et al. (2009) The effect of
hyperoxygenation and reduced flow in fresh water and subsequent infectious
pancreatic necrosis virus challenge in sea water, on the intestinal barrier integrity
in Atlantic salmon, Salmo salar L. J Fish Dis 32: 687–698.
33. Robertsen B (2006) The interferon system of teleost fish. Fish Shellfish Immunol
20: 172–191.
34. Skjesol A, Hansen T, Shi CY, Thim HL, Jørgensen JB (2010) Structural and
functional studies of STAT1 from Atlantic salmon (Salmo salar). BMC Immunol
11: 17.
35. Gadan K, Sandtrø A, Marjara IS, Santi N, Munang’andu HM, et al. (2013)
Stress-induced reversion to virulence of infectious pancreatic necrosis virus in
naive fry of Atlantic Salmon (Salmo salar L.). PLoS One 8: e54656 doi:10.1371/
journal.pone.0054656.
36. Hansen T (1998) Oppdrett av laksesmolt: A/S Landbruksforlaget, Norway. 232
p.
37. Specker JL, Portesi DM, Cornell SC, Veillette PA (1994) Methodology for
implanting cortisol in Atlantic salmon and effects of chronically elevated cortisol
on osmoregulatory physiology. Aquaculture 121: 181–193.
38. Olsvik PA, Lie KK, Jordal AE, Nilsen TO, Hordvik I (2005) Evaluation of
potential reference genes in real-time RT-PCR studies of Atlantic salmon. BMC
Mol Biol 6: 21.
39. Løvoll M, Austbø L, Jørgensen JB, Rimstad E, Frost P (2011) Transcription of
reference genes used for quantitative RT-PCR in Atlantic salmon is affected by
viral infection. Vet Res 42: 8.
40. Sagstad A, Sanden M, Haugland Ø, Hansen AC, Olsvik PA, et al. (2007)
Evaluation of stress- and immune-response biomarkers in Atlantic salmon, Salmo
salar L., fed different levels of genetically modified maize (Bt maize), compared
with its near-isogenic parental line and a commercial suprex maize. J Fish Dis
30: 201–212.
41. Aerts JL, Gonzales MI, Topalian SL (2004) Selection of appropriate control
genes to assess expression of tumor antigens using real-time RT-PCR.
Biotechniques 36: 84-86.
42. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007)
qBase relative quantification framework and software for management and
automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
43. Gadan K, Marjara IS, Sundh H, Sundell K, Evensen Ø (2012) Slow release
cortisol implants result in impaired innate immune responses and higher
infection prevalence following experimental challenge with infectious pancreatic
necrosis virus in Atlantic salmon (Salmo salar) parr. Fish Shellfish Immunol 32:
637–644.
44. Hetland DL, Jørgensen SM, Skjødt K, Dale OB, Falk K, et al. (2010) In situ
localisation of major histocompatibility complex class I and class II and CD8
positive cells in infectious salmon anaemia virus (ISAV)-infected Atlantic salmon.
Fish Shellfish Immunol 28: 30–39.
45. Das BK, Ellis AE, Collet B (2009) Induction and persistence of Mx protein in
tissues, blood and plasma of Atlantic salmon parr, Salmo salar, injected with poly
I:C. Fish Shellfish Immunol 26: 40–48.
46. Jager KJ, van Dijk PC, Zoccali C, Dekker FW (2008) The analysis of survival
data: the Kaplan–Meier method. Kidney Int 74: 560–565.
47. Santi N, Vakharia VN, Evensen Ø (2004) Identification of putative motifs
involved in the virulence of infectious pancreatic necrosis virus. Virology 322:
31–40.
48. McBeath AJ, Snow M, Secombes CJ, Ellis AE, Collet B (2007) Expression
kinetics of interferon and interferon-induced genes in Atlantic salmon (Salmo
salar) following infection with infectious pancreatic necrosis virus and infectious
salmon anaemia virus. Fish Shellfish Immunol 22: 230–241.
49. Sun B, Skjæveland I, Svingerud T, Zou J, Jørgensen J, et al. (2011) Antiviral
activity of salmonid gamma interferon against infectious pancreatic necrosis
virus and salmonid alphavirus and its dependency on type I interferon. J Virol
85: 9188–9198.
50. Hong S, Secombes CJ (2009) Two peptides derived from trout IL-1b have
different stimulatory effects on immune gene expression after intraperitoneal
administration. Comp Biochem Physiol B Biochem Mol Biol 153: 275–280.
51. Skjesol A, Aamo T, Hegseth MN, Robertsen B, Jørgensen JB (2009) The
interplay between infectious pancreatic necrosis virus (IPNV) and the IFN
system: IFN signaling is inhibited by IPNV infection. Virus Research 143: 53–
60.
52. Lee S-H, Vidal SM (2002) Functional diversity of Mx proteins: variations on a
theme of host resistance to infection. Genome Res 12: 527–530.
53. Racicot K, Schmitt A, Ott T (2012) The myxovirus-resistance protein, MX1, is a
component of exosomes secreted by uterine epithelial cells. Am J Reprod
Immunol 67: 498–505.
54. Toyokawa K, Leite F, Ott TL (2007) Cellular localization and function of the
antiviral protein, ovine Mx1 (oMx1): II. The oMx1 protein is a regulator of
secretion in an ovine glandular epithelial cell line. Am J Reprod Immunol 57:
23–33.
55. Parkin J, Cohen B (2001) An overview of the immune system. Lancet 357: 1777–
1789.
56. Maule AG, Schreck CB, Kaattari SL (1987) Changes in the immune-system of
Coho salmon (Oncorhynchus kisutch) during the parr-to-smolt transformation and
after implantation of cortisol. Can J Fish Aquatic Sci 44: 161–166.
57. Miron N, Cristea V (2012) Enterocytes: active cells in tolerance to food and
microbial antigens in the gut. Clin Exp Immunol 167: 405–412.
58. Hershberg RM, Mayer LF (2000) Antigen processing and presentation by
intestinal epithelial cells - polarity and complexity. Immunol Today 21: 123–
128.
59. MGonigle RH (1941) Acute catarrhal enteritis of salmonid fingerlings. Am Fish
Soc 70: 297–303.
60. Smail DA, McFarlane L, Bruno DW, McVicar AH (1995) The pathology of an
IPN-Sp sub-type (Sh) in farmed Atlantic salmon, Salmo salar L, post-smolts in the
Shetland Isles, Scotland. J Fish Dis 18: 631–638.
61. Sundh H, Olsen RE, Fridell F, Gadan K, Evensen Ø, et al. (2009) The effect of
hyperoxygenation and reduced flow in fresh water and subsequent infectious
pancreatic necrosis virus challenge in sea water, on the intestinal barrier integrity
in Atlantic salmon, Salmo salar L. J Fish Dis 32: 687–698.
62. Ozaki A, Sakamoto T, Khoo S, Nakamura K, Coimbra MR, et al. (2001)
Quantitative trait loci (QTLs) associated with resistance/susceptibility to
infectious pancreatic necrosis virus (IPNV) in rainbow trout (Oncorhynchus mykiss).
Mol Genet Genomics 265: 23–31.
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